InvestorsHub Logo
Followers 0
Posts 74
Boards Moderated 0
Alias Born 03/18/2018

Re: None

Wednesday, 08/08/2018 8:54:18 AM

Wednesday, August 08, 2018 8:54:18 AM

Post# of 18784
Strongbridge biopharma (licensee of Macrilen in the USA and Canada) also today reported positive Phase III clinical trial results for Recorlev drug. https://www.nasdaq.com/press-release/strongbridge-biopharma-plc-announces-positive-topline-results-from-the-pivotal-phase-3-sonics-stud-20180808-00315
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEZS News